search
Back to results

POEM vs. Pneumatic Dilation for Esophageal Achalasia

Primary Purpose

Esophageal Achalasia

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
POEM
Pneumatic dilation
Sponsored by
Nanfang Hospital, Southern Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Esophageal Achalasia focused on measuring Esophageal achalasia, Peroral endoscopic myotomy, POEM, Pneumatic dilation

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Between 18 and 75 years of age
  • Patient with esophageal achalasia
  • Eckardt score > 3
  • Signed informed consent

Exclusion Criteria:

  • Severe cardio-pulmonary disease or other serious disease leading to unacceptable surgical risk
  • Pseudo-achalasia, Mega-oesophagus (greater than 7 cm), or Oesophageal diverticula in the distal oesophagus
  • Previous endoscopic Botox injection
  • Previous oesophageal or gastric surgery
  • Pregnancy or lactation women, or ready to pregnant women
  • Not capable of filling out questionnaires

Sites / Locations

  • Nanfang Hospital of Southern Medical UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

POEM

Pneumatic dilation

Arm Description

POEM for patients with esophageal achalasia

Pneumatic dilation for patients with esophageal achalasia

Outcomes

Primary Outcome Measures

Therapeutic success
Therapeutic success is defined as a symptom control to an Eckardt score of 3 or less. The Eckardt score is the sum of the symptom scores for dysphagia, regurgitation, and chest pain (with a score of 0 indicating the absence of symptoms, 1 indicating occasional symptoms, 2 indicating daily symptoms, and 3 indicating symptoms at each meal) and weight loss (with 0 indicating no weight loss, 1 indicating a loss of <5 kg, 2 indicating a loss of 5 to 10 kg, and 3 indicating a loss of >10 kg) (Eckardt, V. Gastroenterology, 1992. 103(6): p. 1732-8.)

Secondary Outcome Measures

Procedure related complication
Perforation, Delayed bleeding, Pneumothorax, Subcutaneous emphysema, Anastomotic leak etc.
Time of treatment failure
Time of treatment failure is defined as when the Eckardt score of patients are more than 3
Pressure at the lower esophageal sphincter
The basal LES pressure and the swallow-induced LES relaxation will be monitored and measured at the end of expiration. After introduction and equilibration, basal pressure is monitored during at least 5 minutes. Swallow-induced relaxation of the sphincter is assessed by 5 ml wet swallows, at least 30 s apart.
Quality of life
Patients will complete the quality-of-life questionnaires (the Medical Outcomes Study 36-Item Short-Form Health Survey, SF-36) for assessing quality of life

Full Information

First Posted
January 5, 2013
Last Updated
January 11, 2013
Sponsor
Nanfang Hospital, Southern Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT01768091
Brief Title
POEM vs. Pneumatic Dilation for Esophageal Achalasia
Official Title
Peroral Endoscopic Myotomy Versus Pneumatic Dilation for Esophageal Achalasia: a Prospective Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2013
Overall Recruitment Status
Unknown status
Study Start Date
December 2011 (undefined)
Primary Completion Date
December 2013 (Anticipated)
Study Completion Date
December 2013 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nanfang Hospital, Southern Medical University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the efficacy and safety of peroral endoscopic myotomy (POEM) compared with pneumatic dilation in the treatment of esophageal achalasia.
Detailed Description
Esophageal achalasia is an esophageal motor disorder, which is characterized by the absence of esophageal peristalsis combined with a defective relaxation of the lower esophageal sphincter (LES). The major symptoms of esophageal achalasia are dysphagia, chest pain, and regurgitation of undigested food. Currently, treatment options mainly focus on relief of the symptoms by reducing the LES pressure. Pneumatic dilation is the main endoscopic therapies for esophageal achalasia. However, the patients need repeat treatment to maintain therapeutic success and there is a risk of perforation (1%-3%). For surgery approaches, the laparoscopic Heller's myotomy (LHM) combined with Dor's antireflux procedure has gained considerable interest. The LHM can sustain therapeutic effects for long-term in approximately 80% of patients. Recently, Inoue et al. succeeded in treating achalasia endoscopically with a method called peroral endoscopic myotomy (POEM) and achieved promising results in short-term. Technically, POEM derived from natural orifice transluminal endoscopic surgery (NOTES) and endoscopic submucosal dissection (ESD), in which a submucosal tunnel is created after submucosal injection, and then an endoscopic myotomy was made at the gastroesophageal junction. However, the long-term efficacy and safety of POEM were not determined, and there was no prospective study that compared the POEM with other conventional treatment. Therefore, we aim to determine the efficacy and safety of POEM, compared with the pneumatic dilation, in the treatment of esophageal achalasia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Achalasia
Keywords
Esophageal achalasia, Peroral endoscopic myotomy, POEM, Pneumatic dilation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
POEM
Arm Type
Experimental
Arm Description
POEM for patients with esophageal achalasia
Arm Title
Pneumatic dilation
Arm Type
Active Comparator
Arm Description
Pneumatic dilation for patients with esophageal achalasia
Intervention Type
Procedure
Intervention Name(s)
POEM
Other Intervention Name(s)
Peroral endoscopic myotomy
Intervention Description
Entry to submucosal space. After submucosal injection, a 2-cm longitudinal mucosal incision is made at approximately 13 cm proximal to the gastroesophageal junction (GEJ). Submucosal tunnelling. A long submucosal tunnel is created to 3 cm distal to the GEJ. Endoscopic myotomy is begun at 3 cm distal to the mucosal entry point, and is carried out in a proximal to distal direction to a total length of 10 cm. Long endoscopic myotomy of inner circular muscle bundles is done, leaving the outer longitudinal muscle layer intact. The expected end point of myotomy is 2 cm distal to the GEJ. Closure of mucosal entry: the mucosal incision is closed using hemostatic clips. (Inoue H et al. POEM for esophageal achalasia… Endoscopy 2010; 42: 265-271)
Intervention Type
Procedure
Intervention Name(s)
Pneumatic dilation
Intervention Description
A Rigiflex balloon (30 mm) was positioned at the esophagogastric junction and dilated at a pressure of 5 PSI for 1 minute, followed by 8 PSI for 1 minute. (N Engl J Med 2011;364:1807-16.)
Primary Outcome Measure Information:
Title
Therapeutic success
Description
Therapeutic success is defined as a symptom control to an Eckardt score of 3 or less. The Eckardt score is the sum of the symptom scores for dysphagia, regurgitation, and chest pain (with a score of 0 indicating the absence of symptoms, 1 indicating occasional symptoms, 2 indicating daily symptoms, and 3 indicating symptoms at each meal) and weight loss (with 0 indicating no weight loss, 1 indicating a loss of <5 kg, 2 indicating a loss of 5 to 10 kg, and 3 indicating a loss of >10 kg) (Eckardt, V. Gastroenterology, 1992. 103(6): p. 1732-8.)
Time Frame
From date of randomization until the follow-up ended, assessed up to 2 years
Secondary Outcome Measure Information:
Title
Procedure related complication
Description
Perforation, Delayed bleeding, Pneumothorax, Subcutaneous emphysema, Anastomotic leak etc.
Time Frame
From date of randomization until the follow-up ended, assessed up to 2 years
Title
Time of treatment failure
Description
Time of treatment failure is defined as when the Eckardt score of patients are more than 3
Time Frame
From date of randomization until the follow-up ended, assessed up to 2 years
Title
Pressure at the lower esophageal sphincter
Description
The basal LES pressure and the swallow-induced LES relaxation will be monitored and measured at the end of expiration. After introduction and equilibration, basal pressure is monitored during at least 5 minutes. Swallow-induced relaxation of the sphincter is assessed by 5 ml wet swallows, at least 30 s apart.
Time Frame
From date of randomization until the follow-up ended, assessed up to 2 years
Title
Quality of life
Description
Patients will complete the quality-of-life questionnaires (the Medical Outcomes Study 36-Item Short-Form Health Survey, SF-36) for assessing quality of life
Time Frame
From date of randomization until the follow-up ended, assessed up to 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Between 18 and 75 years of age Patient with esophageal achalasia Eckardt score > 3 Signed informed consent Exclusion Criteria: Severe cardio-pulmonary disease or other serious disease leading to unacceptable surgical risk Pseudo-achalasia, Mega-oesophagus (greater than 7 cm), or Oesophageal diverticula in the distal oesophagus Previous endoscopic Botox injection Previous oesophageal or gastric surgery Pregnancy or lactation women, or ready to pregnant women Not capable of filling out questionnaires
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Wei Gong, M.D.
Phone
+86 15820290385
Email
gwei203@yahoo.com.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wei Gong, M.D.
Organizational Affiliation
Department of Gastroenterology, Nanfang Hospital of Southern Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nanfang Hospital of Southern Medical University
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510515
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiaobing Cui, M.D.
Phone
+86 13631312723
Email
xbing119@gmail.com

12. IPD Sharing Statement

Citations:
PubMed Identifier
20354937
Citation
Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010 Apr;42(4):265-71. doi: 10.1055/s-0029-1244080. Epub 2010 Mar 30.
Results Reference
background
PubMed Identifier
21561346
Citation
Boeckxstaens GE, Annese V, des Varannes SB, Chaussade S, Costantini M, Cuttitta A, Elizalde JI, Fumagalli U, Gaudric M, Rohof WO, Smout AJ, Tack J, Zwinderman AH, Zaninotto G, Busch OR; European Achalasia Trial Investigators. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med. 2011 May 12;364(19):1807-16. doi: 10.1056/NEJMoa1010502.
Results Reference
background
Links:
URL
http://www.nfyy.com/
Description
Homepage of Nanfang Hospital of Southern Medical University
URL
http://www.xhbnet.com/
Description
Homepage of Department of Gastroenterology, Nanfang Hospital of Southern Medical University

Learn more about this trial

POEM vs. Pneumatic Dilation for Esophageal Achalasia

We'll reach out to this number within 24 hrs